Yuqi Jiang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
In our previous study, we designed and synthesized a novel series of N-hydroxycinnamamide-based HDAC inhibitors (HDACIs), among which the representative compound 14a exhibited promising HDACs inhibition and antitumor activity. In this current study, we report the development of a more potent class of N-hydroxycinnamamide-based HDACIs, using 14a as lead,(More)
  • 1